Standout Papers

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma 2016 2026 2019 2022 1.0k
  1. Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma (2016)
    Antonio Palumbo, Asher Chanan‐Khan et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 6 from Science/Nature 61 standout
Sub-graph 1 of 20

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
3 intermediate papers

Works of Ivan Špıčka being referenced

Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression
2007

Author Peers

Author Last Decade Papers Cites
Ivan Špıčka 3192 2149 2451 167 3.8k
Antonio Palumbo 3391 1963 2574 127 4.0k
Lotfi Benboubker 2481 1686 2252 100 3.2k
Martin Kaiser 2829 1923 2894 203 4.6k
Kazuyuki Shimizu 2384 1655 1621 66 3.2k
Peter Gimsing 2028 1395 1815 109 3.0k
Donna M. Weber 2604 1582 2322 130 3.5k
Massimo Offidani 1957 1385 1367 144 3.0k
Niklas Zojer 1737 1120 1713 122 2.7k
Alessandro Corso 2353 1580 1622 110 3.2k
Jeffrey A. Zonder 2621 1896 2810 193 4.5k

All Works

Loading papers...

Rankless by CCL
2026